Outside of getting excited about playoff hockey and snowboard trips out west, I also find myself enthusiastic about studies/efforts in cancer biology that push the boundaries to further characterize pre-clinical cancer models in a clinical way. The study presented in...
Throughout the last 100 years, numerous milestones in the study and treatment of cancer have been achieved. Discoveries like combination chemotherapy, correlation of smoking and lung cancer, HPV and cervical carcinogenesis, BRCA-1&2 gene inheritance and breast...
January 10th, 2018 – Xstrahl today released an upgrade to its Concerto software streamlining the clinical workflow for the entire range of the Xstrahl systems. Concerto 2.0 provides a streamlined workflow, enhanced connectivity options and a treatment verification...
Xstrahl today released an upgrade to its Concerto software streamlining the clinical workflow for the entire range of the Xstrahl systems. Concerto 2.0 provides a streamlined workflow, enhanced connectivity options and a treatment verification module. The key workflow...
January 4th, 2018 – The Xstrahl Group officially announced that Adrian Treverton has been promoted to Group CEO. This comes as the previous CEO, Martin Robinson retired in the new year after working for the company nearly 20 years. Adrian had more than 10 years of...
With skin cancer being the most common type of cancer in the USA the need for an effective and versatile treatment method is a necessity for many skin cancer centers. The Xstrahl 100 is perfectly suited for the treatment of superficial skin cancers, as used by the...
The radiosensitizing efficacy of gold is well established, however, there remain several significant barriers to the successful clinical translation of nano-sized gold particles (AuNPs). These barriers include: retaining stability in relevant biological sera,...
Minibeam radiation therapy (MBRT) is an innovative synchrotron radiotherapy technique able to shift the normal tissue complication probability curves to significantly higher doses. However, its exploration was hindered due to the limited and expensive beamtime at...
Many radiotherapy research centers have recently installed novel research platforms enabling the investigation of the radiation response of tumors and normal tissues in small animal models, possibly in combination with other treatment modalities. Many more research...